J.P. Morgan reduces its stake in SINOPHARM (01099) by approximately 1.22 million shares, with a price of around HK$19.87 per share.
On February 18, J.P. Morgan reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,221,708 shares, with each share priced at HK$19.8733.
According to the latest data from the Hong Kong Stock Exchange, on February 18th, J.P. Morgan reduced its holdings of SINOPHARM (01099) by 1,221,708 shares, with an average price of HK$19.8733 per share, for a total amount of approximately HK$24.2794 million. After the reduction, the latest number of shares held is approximately 107 million shares, and the latest shareholding ratio is 7.96%.
Related Articles
China Securities Co.,Ltd.: A-shares have currently started a second round of recovery rally.
Accounting for 11.21% of DUIBA's (01753) total share capital! The largest founder donation to an ESOP by share ratio in Hong Kong stock market history
BANK OF GUIZHOU (06199): Wen Zhichao's qualification to serve as an independent non-executive director has been approved.
China Securities Co.,Ltd.: A-shares have currently started a second round of recovery rally.
Accounting for 11.21% of DUIBA's (01753) total share capital! The largest founder donation to an ESOP by share ratio in Hong Kong stock market history
BANK OF GUIZHOU (06199): Wen Zhichao's qualification to serve as an independent non-executive director has been approved.
RECOMMEND
